中国实用儿科杂志 ›› 2025, Vol. 40 ›› Issue (9): 705-713.DOI: 10.19538/j.ek2025090601

• 指南解读 •    下一篇

重视先天性心脏病相关神经发育迟缓或障碍的规范化筛查、评估与管理:2024年美国心脏协会声明解读

  

  1. 浙江大学医学院附属儿童医院 国家儿童健康与疾病临床医学研究中心,浙江  杭州  310052


  • 出版日期:2025-09-06 发布日期:2025-10-20
  • 通讯作者: 张晨美,电子信箱:chzcm@zju.edu.cn
  • 基金资助:
    国家重点研发计划(2021YFC2701800、2021YFC2701801)

Attention to standardized screening,evaluation, and management of neurodevelopmental delays and disorders associated with congenital heart disease:interpretation of the 2024 AHA statement

  1. Children’s Hospital,Zhejiang University School of Medicine;National Clinical Research Center for Child Health,Hangzhou  310052,China
  • Online:2025-09-06 Published:2025-10-20

摘要:

先天性心脏病(congenital heart disease, CHD)相关的神经发育迟缓或障碍已成为全球性挑战,但在国内的关注度仍然有限。当前国内医疗体系对CHD主要集中于外科治疗,而忽视了术后长期随访及神经发育管理的重要性。该解读汇总CHD领域的最新研究进展,系统阐述神经保护策略及风险分层方法,旨在优化临床管理,改善国内CHD患儿的神经发育结局。

关键词:

Abstract:

Neurodevelopmental delays or disorders associated with congenital heart disease (CHD) have become a global challenge;however, the concerns about them remain limited in China. The current healthcare system primarily focuses on surgical treatment for CHD, often overlooking the importance of long-term postoperative follow-up and neurodevelopmental management. This interpretation summarizes the latest advancements in the field of CHD,systematically elaborating on neuroprotection strategies and risk stratification methods, and aiming to optimize clinical management and improve neurodevelopmental outcomes of children with CHD in China.

Key words: